Published: Tue, May 04, 2021
Science | By

Denmark drops J&J from vaccine program

Denmark drops J&J from vaccine program

The advice is nearly identical to that issued for the Oxford-AstraZeneca vaccine last month and comes as both are suspected of causing a new and very rare blood clotting syndrome.

The CDC says the reactions were temporary, and none were what they consider serious.

While each vaccine is available at the site, the choice must be made when people are booking their appointment.

However, the AZ vaccines have already been distributed in Canada and administered across the country.

"The Danish Health Authority has concluded that the benefits of using the Covid-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse those who receive the vaccine", the authority said in a statement.

Plans to distribute the first 300,000 doses of the Johnson & Johnson COVID-19 vaccine in Canada next week are on hold after Health Canada learned part of them were manufactured at a Maryland facility that messed up the ingredients in 15 million doses bound for the USA market.

"If someone's working from home, not really going out, in a province or territory where there's not much disease, then they're in a very different situation than somebody that works in, let's say, a manufacturing plant, has some difficulty wearing PPE, and in a province that has a very high burden of disease", said Deeks. All were women, most under age 50.

"This is encouraging that we can do over 9,000 people next week through our drive-throughs in the major centres and get them fully vaccinated", said Merriman. They lifted the pause on April. 23, and now, more than one week after the vaccine went back into circulation, new research from the CDC has offered some further reassurance in the single-shot vaccine.

France's Covid vaccination calendar: Who is eligible and when? About 1.7 million doses have been given out as of April 24.

In mid-April, Denmark announced it was dropping the AstraZeneca vaccine after putting it on hold a month earlier, citing similar concerns, becoming the first country in Europe to completely cut the vaccine.

Pfizer and Moderna use mRNA technology, attaching the spike protein to messenger RNA, a molecule that delivers messages to the body to carry out certain functions.

Johnson & Johnson's one-dose vaccine returned to the large-scale vaccination clinic in Worcester this week. Some data is expected on that this month.

"Johnson & Johnson may be better suited for populations that are harder to schedule for a second dose", Deeks said.

Like this: